This book represents the most comprehensive compilation of data on threatened vascular plants ever published. It includes the names of some 33,000 plant species determined to be rare or threatened on a global scale. Conservation assessments were provided by the IUCN Species Survival Commission, the National Botanical Institute (South Africa), Environment Australia, and CSIRO, The Nature Conservancy, the Smithsonian Institution, and the Royal Botanic Gardens, Kew, together with hundreds of botanic gardens and botanists throughout the world. The Royal Botanic Gardens Edinburgh and the New York Botanical Garden have made major in-kind contributions.The result of 20 years work by botanists and conservationists around the world, it is intended as a conservation tool, a provider of baseline information to measure conservation progress and as a primary source of data on plant species. Most importantly, however, it provides the building blocks on which to base a worldwide effort to conserve plant species.

Applies Red List data to calculate a Red List Index.

Release of the 2000 Red List is a major landmark for IUCN. It is the first time that listings of animals and plants have been combined and the first time that the Red List has been produced on CD-ROM. The 2000 Red List combines new assessmentsincluding all bird species, many antelope and bat species, most primates and sharks, all Asian freshwater turtles, more molluscs, and many otherswith those from previous publications. The combination of animals and plants into a single list containing assessments of more than 18,000 taxa (11,000 of which are threatened species) and the move towards improved documentation of each species on the list means that a hard-copy version of the Red List would run to several volumes. This, combined with the fact that the Red List will be updated annually, led to the decision to release the Red List in electronic format, via the World Wide Web and as a CD-ROM.

Medicinal plants are globally valuable sources of herbal products. Plant-based remedies have been used for centuries and have had no alternative in the western medicine repertoire, while others and their bioactive derivatives are in high demand and have been the central focus of biomedical research. As Medicinal plants move from fringe to mainstream with a greater number of individuals seeking treatments free of side effects, considerable attention has been paid to utilize plant-based products for the prevention and cure of human diseases. An unintended consequence of this increased demand, however, is that the existence of many medicinal plants is now threatened, due to their small population size, narrow distribution area, habitat specificity, and destructive mode of harvesting. In addition, climate change, habitat loss and genetic drift have further endangered these unique species. Although extensive research has been carried out on medicinal and aromatic plants, there is relatively little information available on their global distribution patterns, conservation and the associated laws prevailing. This book reviews the current status of threatened medicinal plants in light of increased surge in the demand for herbal medicine. It brings together chapters on both wild (non-cultivated) and domestic (cultivated) species having therapeutic values. Thematically, conventional and contemporary approaches to conservation of such threatened medicinal plants with commercial feasibility are presented. The topics of interest include, but not limited to, biotechnology, sustainable development, in situ and ex situ conservation, and even the relevance of IPR on threatened medicinal plants. We believe this book is useful to horticulturists, botanists, policy makers, conservationists, NGOs and researchers in the academia and the industry sectors.